AADR vs BCVAX
AADR is an ETF, whereas BCVAX is a mutual fund. Below is the comparison between AADR and BCVAX.
| AADR | BCVAX | |
|---|---|---|
| Security Type | ETF | Mutual fund |
| Segment | Equity: Global Ex-U.S. - Total Market Growth | N/A |
| Family | AdvisorShares | N/A |
| Net Assets | $43.70M | N/A |
| Expense Ratio | 1.10% | N/A |
| Management Style | passive (index-based) | passive |
| Dividend Yield | 0.31% | N/A |
| Minimum Investment | N/A | N/A |
| YTD Return | -23.35% | N/A |
| 1-Year Return | -24.53% | N/A |
| 3-Year Return | -1.29% | N/A |
| 5-Year Return | 3.90% | N/A |
| 10-Year Return | 6.44% | N/A |
AADR
AADR description
The Fund seeks long-term capital appreciation above international benchmarks such as the MSCI EAFE Index and the BNY Mellon Classic ADR Index. The Fund selects a portfolio of U.S. traded securities of non-U.S. organizations, most often American Depositary Receipts (ADRs), included in the BNY Mellon Classic ADR Index.
AADR performance & returns
| YTD Return | -23.35% |
| 1-Month Return | -0.50% |
| 3-Month Return | -12.96% |
| 1-Year Return | -24.53% |
| 3-Year Return | -1.29% |
| 5-Year Return | 3.90% |
| 10-Year Return | 6.44% |
AADR expense ratio is 1.1%.
AADR holdings
Top 10 Holdings (38.80% of Total Assets)
| Name | Symbol | % Assets |
|---|---|---|
| ASML Holding NV ADR | ASML | 5.52% |
| BioNTech SE ADR | BNTX.DE | 4.57% |
| Danaos Corp | DAC.AX | 4.48% |
| LVMH Moet Hennessy Louis Vuitton SE ADR | LVMUY.PA | 4.16% |
| Himax Technologies Inc ADR | HIMX | 3.79% |
| Sibanye Stillwater Ltd ADR | SBSW.JO | 3.64% |
| Logitech International SA | LOGN | 3.51% |
| Cemex SAB de CV ADR | CX.MX | 3.22% |
| Embraer SA ADR | ERJ.SA | 3.06% |
| POSCO ADR | PKX.KS | 2.85% |
AADR pros
None that we could think of.AADR cons
None that we could think of.Other relevant AADR comparisons
You may also want to check out the following AADR comparisons that investors often look for on Finny
Or use Finny's Comparison Tool to create a comparison you'd like to see.
BCVAX
BCVAX description
null
BCVAX performance & returns
| YTD Return | N/A |
| 1-Month Return | N/A |
| 3-Month Return | N/A |
| 1-Year Return | N/A |
| 3-Year Return | N/A |
| 5-Year Return | N/A |
| 10-Year Return | N/A |
BCVAX expense ratio is N/A.
BCVAX pros
None that we could think of.BCVAX cons
None that we could think of.Other relevant BCVAX comparisons
You may also want to check out the following BCVAX comparisons that investors often look for on Finny
Or use Finny's Comparison Tool to create a comparison you'd like to see.